Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of Tuesday, October 6, 2026.
NET PROFIT MARGIN
N/A
Scribe Therapeutics Inc.
Market Cap
$264.25M
Net Profit Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$262.92M
Net Profit Margin
-62.59%
TTM Avg
-99.90%
3Y Avg
-225.27%
5Y Avg
-207.41%
Market Cap
$265.78M
Net Profit Margin
-10994.73%
TTM Avg
-520.92%
3Y Avg
-360.66%
5Y Avg
-288.77%
Market Cap
$266.59M
Net Profit Margin
0.00%
TTM Avg
-1289.52%
3Y Avg
-1135.48%
5Y Avg
-755.61%
Market Cap
$266.92M
Net Profit Margin
-1941.09%
TTM Avg
-1708.77%
3Y Avg
-990.85%
5Y Avg
-815.81%
Market Cap
$261.43M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-5482.65%
5Y Avg
-3802.53%
Market Cap
$261.27M
Net Profit Margin
-568.80%
TTM Avg
-845.08%
3Y Avg
-422.54%
5Y Avg
-626.87%
Market Cap
$259.56M
Net Profit Margin
-43.70%
TTM Avg
-35.13%
3Y Avg
-15.36%
5Y Avg
-13.33%
Market Cap
$259.49M
Net Profit Margin
-28.99%
TTM Avg
-27.18%
3Y Avg
-27.76%
5Y Avg
-23.20%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scribe Therapeutics Inc. (SCTX) | $264.25M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | -62.59% | -99.90% | -225.27% | -207.41% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.78M | -10994.73% | -520.92% | -360.66% | -288.77% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $266.59M | 0.00% | -1289.52% | -1135.48% | -755.61% |
| Fate Therapeutics, Inc. (FATE)vs › | $266.92M | -1941.09% | -1708.77% | -990.85% | -815.81% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | 0.00% | 0.00% | -5482.65% | -3802.53% |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | -568.80% | -845.08% | -422.54% | -626.87% |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | -43.70% | -35.13% | -15.36% | -13.33% |
| Treace Medical Concepts, Inc. (TMCI)vs › | $259.49M | -28.99% | -27.18% | -27.76% | -23.20% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
